HOME >> BIOLOGY >> NEWS
New treatment increases life time expectancy of patients suffering from advanced liver cancer

A trial designed and co-led by Dr. Jordi Bruix, head of the Hepatology Service of Hospital Clnic- IDIBAPS (Barcelona) and Dr. Josep Maria Llovet, ICREA researcher of the Hepatic Oncology Group, are planning a new treatment which increases the overall survival of patients suffering from advanced liver cancer. The results of this study, called SHARP (Sorafenib HCC hepatocellular carcinoma Assessment Randomized Protocol) allow overall survival (OS) and time to symptom progression (TTSP) comparison between patients who were administered Sorafenib orally, (developed by BAYER) and another group of patients, treated with placebo. The results presented by Clnic-IDIBAPS investigators have been hand selected to be included on the Best of ASCO program. This is an educational initiative that condenses highlights from ASCOs Annual Meeting into a 1 day program.

Results are consistent and significant. Overall survival of patients treated with Sorafenib was in average 10.7 months compared to 7.9 months within the group administered placebo. Thus, this treatment increases overall survival by more than 40% if compared to the placebo group. Furthermore, no differences were observed in the severe side effects rate between the treatments two modalities. Obtained data imply an unprecedented therapeutic progress in the treatment of advanced liver cancer and involve a shift in this diseases paradigm. This treatment gives new hope for patients who, until now, could neither beneficiate from curative effects of therapies nor hope for survival improvement. From a scientific point of view, this drug, which delays tumor progression and improves survival, will be the base for future further research.

The SHARP study, an international phase III trial, lead by Hospital Clnic in collaboration with Mount Sinai, where Dr. Llovet is head of the Hepatic Cancer Research Program, started 5 years ago and included a total of 602 patients from 110 centers from the
'"/>

Contact: lex Argem
aargemi@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
4-Jun-2007


Page: 1 2 3

Related biology news :

1. New system of wastewater treatment could reduce the size of treatment plants by half
2. UCF research links proteins, stem cells and potential Alzheimers treatment
3. Geisinger scientist seeks cure for Lou Gehrigs disease, creating device to find treatment
4. System to analyze beating heart stem cells could lead to heart attack treatments
5. Gene expression pattern could lead to improved treatment of pediatric septic shock
6. Molecular detectors may refine cancer treatment
7. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
8. A new method of adult stem cell growth efficacious in treatment of disorders of the cornea
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. New treatment model for HIV
11. New research shows vaginal bacteria vary among healthy women, need customized treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2020)... ... March 02, 2020 , ... Nominations are now being accepted ... the Security Industry Association (SIA) and SecureIDNews and co-presented with ... Security Forum . The recipients of this year’s Women in Biometrics Awards will be ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... PRF® devices are now available to veterinary practices through Covetrus. Enso Discoveries ... will provide the most affordable, easiest to use, multi-species validated, platelet-rich plasma ...
(Date:2/28/2020)... ... February 27, 2020 , ... ... newest portfolio company. Established to develop and commercialize a manufacturing platform for ... Mexico State University (NMSU). The patent-pending technology results in membranes with controllable ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... (PRWEB) , ... February 20, 2020 , ... ... ensuring supply chain transparency and reassuring consumers that what’s listed on an ingredient ... trademarked ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which ...
(Date:2/19/2020)... ... 2020 , ... Shoreline Biome, a microbiome research ... recently unveiled a novel DNA isolation product. , Shoreline Rapid Prep is a ... weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB from Gram-negative bacteria, ...
(Date:2/13/2020)... ... February 12, 2020 , ... ... and services, is adopting Veeva Vault Safety™ as part of the ... fast assessment of data, processing of safety information such as SUSARs and ICSRS, ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced ... March 13-14th, 2020 in Las Vegas. The course is hands on involving real patients ... the past few years, the Comprehensive Stem Cell Training Course has received rave reviews ...
Breaking Biology Technology:
Cached News: